Lantern Pharma Statistics
NASDAQ: LTRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8127-0.0173 (-2.08%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.8127 0.00%
Lantern Pharma by the numbers
Lantern Pharma has a market capitalization of $12.1 million based on 14.94M shares outstanding. With trailing EPS of $-1.63, Lantern Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 57.8% below its 50-day average and 69.6% below its 200-day average.
Average daily trading volume is 180.42K shares, or about $146,627 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LTRN valuation vs. peer median
| Metric | LTRN | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.14M | $11.81M | +3% |
| Avg. volume | 180.42K | 442.51K | -59% |
Peer median across 8 companies: BIVI, GTBP, BFRG, ASBP, LSTA, TPST, PHIO, KPRX.
Valuation
- Market cap
- $12.14M
- EPS (TTM)
- $-1.63
- Shares outstanding
- 14.94M
Price and trading
- Previous close
- 0.83
- Open
- 0.83
- Day range
- 0.7603 – 0.8301
- 52-week range
- 0.7603 – 4.68
- 52-week change
- -81.92%
- Beta
- —
- Volume
- 274.78K
- Average volume
- 180.42K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 12.14M
- Forward Pe
- -0.40
- Eps
- -1.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.68
- Week52 Low
- 0.76
- Avg Volume
- 180.42K
- Shares Outstanding
- 14.94M
- Ma50
- 1.93
- Ma200
- 2.68
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -82.63%
- Pct From52w Low
- 6.89%